We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBTYK icon
13451
PUT
Liberty Global Class C
LBTYK
$3.53B
-9,700
Closed -$251K
LCFY icon
13452
Locafy
LCFY
$6.11M
-952
Closed -$45K
LCTX icon
13453
CALL
Lineage Cell Therapeutics
LCTX
$268M
-27,600
Closed -$43K
LCTX icon
13454
PUT
Lineage Cell Therapeutics
LCTX
$268M
-13,400
Closed -$21K
LDTCW
13455
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
-166,666
Closed -$47K
LE icon
13456
CALL
Lands' End
LE
$376M
-20,000
Closed -$338K
LE icon
13457
PUT
Lands' End
LE
$376M
-42,200
Closed -$714K
LEGH icon
13458
Legacy Housing
LEGH
$699M
-9,798
Closed -$211K
LEGR icon
13459
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$135M
-29,880
Closed -$1.21M
LEU icon
13460
Centrus Energy
LEU
$3.91B
-10,303
Closed -$285K
LFCR icon
13461
CALL
Lifecore Biomedical
LFCR
$174M
-11,100
Closed -$129K
LFT
13462
Lument Finance Trust
LFT
$34.6M
-20,110
Closed -$55K
LGHL
13463
Lion Group Holding
LGHL
$676K
0
LGHL
13464
PUT
Lion Group Holding
LGHL
$676K
0
-$19K
LGND icon
13465
Ligand Pharmaceuticals
LGND
$5.83B
-2,982
Closed -$169K
LGO
13466
Largo
LGO
$75.1M
-11,050
Closed -$101K
LGO
13467
PUT
Largo
LGO
$75.1M
-12,200
Closed -$155K
LIDRW icon
13468
AEye Inc Warrant
LIDRW
$48.6K
-150,110
Closed -$170K
LIDR icon
13469
AEye
LIDR
$61.4M
-1,756
Closed -$237K
LILA icon
13470
CALL
Liberty Latin America Class A
LILA
$1.67B
-19,283
Closed -$127K
LILAK icon
13471
Liberty Latin America Class C
LILAK
$1.65B
-90,038
Closed -$785K
LILAK icon
13472
PUT
Liberty Latin America Class C
LILAK
$1.65B
-48,070
Closed -$419K
LIND icon
13473
PUT
Lindblad Expeditions
LIND
$2.24B
-49,700
Closed -$749K
LITB
13474
LightInTheBox
LITB
$54M
-2,288
Closed -$14K
LMAT icon
13475
CALL
LeMaitre Vascular
LMAT
$1.88B
-10,400
Closed -$483K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.